Search

Author/Creator Case, Thomas

2. Glucocorticoids are induced while dihydrotestosterone levels are suppressed in 5‐alpha reductase inhibitor treated human benign prostate hyperplasia patients. Issue 14 (12th July 2022)

Authors:
Jin, Renjie; Forbes, Connor; Miller, Nicole L.; Strand, Douglas; Case, Thomas; Cates, Justin M.; Kim, Hye‐Young H.; Wages, Phillip; Porter, Ned A.; Mantione, Krystin M.; Burke, Sarah; Mohler, James L.; Matusik, Robert J.
Journal:
Prostate
Issue:
Volume 82:Issue 14(2022)
Page Start:
1378
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. PD16-10 5-ALPHA REDUCTASE INHIBITORS SUPPRESS DIHYDROTESTOSTERONE IN BENIGN PROSTATE HYPERPLASIA REQUIRING SURGERY, AND CAUSE STEROIDOGENESIS VIA 5ARI INDUCED PATHWAY. (May 2022)

Authors:
Forbes, Connor; Miller, Nicole L; Case, Thomas; Strand, Douglas; Liu, Qi; Ramirez-Solano, Marisol; Cates, Justin M.; Porter, Ned A.; Kim, Hye-Young H.; Wages, Phillip; Mohler, James L.; Matusik, Robert J.; Jin, Ren Jie
Journal:
Journal of urology
Issue:
Volume 207(2022)Supplement 5
Page Start:
e272
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. The prostaglandin pathway is activated in patients who fail medical therapy for benign prostatic hyperplasia with lower urinary tract symptoms. Issue 13 (20th July 2021)

Authors:
Jin, RenJie; Strand, Douglas W.; Forbes, Connor M.; Case, Thomas; Cates, Justin M. M.; Liu, Qi; Ramirez‐Solano, Marisol; Milne, Ginger L.; Sanchez, Stephanie; Wang, Zunyi Y.; Bjorling, Dale E.; Miller, Nicole L.; Matusik, Robert J.
Journal:
Prostate
Issue:
Volume 81:Issue 13(2021)
Page Start:
944
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗